Morgan Stanley Resumes Coverage of Covidien (COV), Baxter (BAX), Becton Dickinson (BDX), Hospira (HSP), Integra (IART)
More News related to BAX
- Baxter (BAX) Raises Qtr Dividend 12% to $0.29/Share, 2.1% Yield
- Baxter Raises Quarterly Dividend
- New Medicare Benefit to Provide Chronic Kidney Disease Patients with Education on Treatment Options
- Baxter to Present at the 2009 Annual Credit Suisse Health Care Conference
- Don't Miss Out! The Registration Period for the 2010 IR Global Rankings Ends TOMORROW!
More News related to BDX
- BD to Present at Investor Healthcare Conferences
- Becton Dickinson (BDX) Reports In-Line Q4 EPS; Guides
- BD Announces Results for Fourth Fiscal Quarter and Full Year
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- University of Michigan Wolverine Venture Fund Continues Track Record of Industry Firsts
More News related to COV
- Covidien to Present at Lazard Capital Markets Conference
- Covidien Submits Label Change for Optimark(TM) Contrast Agent
- Covidien Completes Acquisition of Aspect Medical Systems Inc.
- Covidien Successfully Completes Tender Offer for Shares of Aspect Medical Systems, Inc.
- Covidien (COV) and Nuvo Research Announce the U.S. FDA Approved New Drug Application for Pennsaid
More News related to New Coverage
- Miller Tabak Initiates Coverage on Oclaro (OCLR) with a Buy
- Natixis Bleichroeder Initiates Coverage on Gen-Probe (GPRO) with a Buy
- Craig-Hallum Initiates Coverage on Onyx Pharmaceuticals (ONXX) with a Buy
- Stifel Nicolaus Initiates Coverage on Hudson Valley Holding (HUVL) with a Hold
- Bernstein Initiates Coverage on Hyatt Hotels (H) with an Underperform
After the close today, Morgan Stanley resumed coverage of several stocks in the Healthcare sector:
with an Overweight rating:
with an Underweight rating:
- Integra LifeSciences (Nasdaq: IART)
Related Categories
New CoverageStocks Mentioned
-0.15
+0.30Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
